INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,537 | $9.49 | 10,887 |
| Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 89,463 | $9.49 | 89,813 |
| Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,537 | -- | -- |
| Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 89,463 | -- | -- |
| Sep 29, 2008 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $8.77 | 25,350 |
| Sep 29, 2008 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | -- |
| Apr 20, 2007 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $8.77 | 29,297 |
| Apr 20, 2007 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 25,000 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,311 | $10.56 | 22,198 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 24,226 | $10.56 | 33,873 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.